FullDNA

Company Overview

Snapshot

Founded in July 2019, FullDNA operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its genetics-based health prediction platform.

Business overview

FullDNA specializes in an AI-based, customizable genetics health prediction platform designed to enhance the capabilities of health professionals and institutions. The company's core technology analyzes DNA sequencing results using artificial intelligence and complex algorithms, comparing them with its proprietary database to generate analysis and recommendation reports across various health, wellness, and sports domains. FullDNA serves markets within the Health Tech & Life Sciences sector, specifically targeting digital healthcare, digital medical diagnostics, and healthcare providers and laboratories with its B2B2C and B2B business models.

Company Intelligence Q&A

What is FullDNA's primary business model?

FullDNA operates with both B2B2C and B2B business models, providing its genetics-based health prediction platform to health professionals and institutions.

When was FullDNA founded?

FullDNA was founded in July 2019.

What is the current status of FullDNA?

FullDNA is currently non-active and ceased to operate in December 2024.

Which sectors does FullDNA primarily operate in?

FullDNA primarily operates within the Health Tech & Life Sciences sector, focusing on digital healthcare and digital medical diagnostics.

What technology does FullDNA utilize in its platform?

FullDNA utilizes artificial intelligence and complex algorithms to analyze DNA sequencing results and generate health prediction reports.